Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.18 USD | +1.22% |
|
-2.23% | -2.59% |
01/07 | Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 3000 Value Index | CI |
01/07 | Syndax Pharmaceuticals, Inc.(NasdaqGS:SNDX) dropped from Russell 2500 Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.59% | 177.88Cr | |
+16.62% | 4.53TCr | |
+42.10% | 4.04TCr | |
-9.89% | 3.79TCr | |
+33.16% | 3.18TCr | |
-8.98% | 2.77TCr | |
+13.13% | 2.65TCr | |
+44.54% | 1.4TCr | |
+32.85% | 1.24TCr | |
-7.31% | 1.13TCr |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Transcript : Syndax Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 10